Kasia A. Sablik
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
ARHGDIB and AT1R autoantibodies are differentially related to the development and presence of chronic antibody-mediated rejection and fibrosis in kidney allografts.
Journal: Human immunology
Published: October 28, 2020
Immune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection.
Journal: Frontiers in immunology
Published: July 06, 2019
Banff lesions and renal allograft survival in chronic-active antibody mediated rejection.
Journal: Transplant immunology
Published: April 12, 2019
Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection.
Journal: BMC nephrology
Published: November 27, 2018
Increased CD16 expression on NK cells is indicative of antibody-dependent cell-mediated cytotoxicity in chronic-active antibody-mediated rejection.
Journal: Transplant immunology
Published: September 27, 2018
Chronic-active antibody-mediated rejection with or without donor-specific antibodies has similar histomorphology and clinical outcome - a retrospective study.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: November 17, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026